New Study Demonstrates Ivermectin Superior Over Other Treatments

Researchers used computational analysis to evaluate the performance of 10 medications against the omicron mutation. The study found ivermectin outperformed all of them, including Pfizer’s nirmatrelvir (Paxlovid). Paxlovid, a new medication from the Big Pharma cartel, cost tax-payers $5.29 billion and costs $529 per course of treatment. Ivermectin lowers the viral load by inhibiting replication, … Continue reading New Study Demonstrates Ivermectin Superior Over Other Treatments